MAY 24, 2018 09:00 AM PDT

Dissecting the Tumor Microenvironment Part 1 - Tools for Isolation and Flow Analysis

SPONSORED BY: Miltenyi Biotec
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Manager of R&D Oncology, Miltenyi Biotec
    Biography
      Dr. Olaf Hardt obtained his Ph.D. at the University of Cologne, Germany in collaboration with Miltenyi Biotec and the IBDML in Marseille, France before he started as R&D Project Manager at Miltenyi Biotec in 2008. In his current position as Manager R&D Oncology for Miltenyi Biotec in Bergisch Gladbach, Germany, he focuses on immuno-oncology preclinical research, target discovery, as well as oncology related product development. He also heads the transgenic unit and animal facility.

    Abstract:

    DATE: May 24, 2018
    TIME: 9:00AM PDT, 5:00PM CET

    Isolation of tumor cells and tumor-infiltrating leukocytes for optimized downstream analysis

    Recent advances in immuno-oncology research have proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells within the tumor microenvironment is key to developing future immune based cancer therapy strategies. However, the most significant challenge to working with solid tumors is the need to dissociate the samples prior to their use in downstream applications, such as immunomagnetic enrichment, flow cytometry, and single-cell sequencing. Furthermore, tumor cells can cause background signals and introduce bias to the analysis of immune cells.

    Learning Objectives:

    •    Optimized and automated dissociation of tumor tissue resulting in high yield, viability, and improved cell surface marker detection

    •    Analysis of tumor cells by flow cytometry

    •    Isolation of tumor subpopulations for enhancing NGS based analyses

    •    Isolation and analysis of tumor-infiltrating immune cell subpopulations (TILs)

     

     

     

     

     

     

     

     


    Show Resources
    You May Also Like
    MAY 24, 2018 09:30 AM PDT
    C.E. CREDITS
    MAY 24, 2018 09:30 AM PDT
    DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    JUN 29, 2018 09:00 AM PDT
    C.E. CREDITS
    JUN 29, 2018 09:00 AM PDT
    DATE: June 29, 2018TIME: 09:00AM PDT, 12:00PM EDT There is significant epidemiological evidence to suggest that the consumption of a high-broccoli diet is associated with a r...
    MAY 29, 2018 09:00 AM PDT
    C.E. CREDITS
    MAY 29, 2018 09:00 AM PDT
    Recent advances in immuno-oncology research has proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells withi...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    Loading Comments...